Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
DarioHealth, HMC HealthWorks announce partnership agreement » 08:34
09/21/20
09/21
08:34
09/21/20
08:34
DRIO

DarioHealth

$18.92 /

+1.52 (+8.74%)

DarioHealth and HMC…

DarioHealth and HMC HealthWorks announced that the companies have entered into a sales and distribution partnership pursuant to which HMC will incorporate DarioHealth's digital therapeutics solution into its comprehensive care management programs. HMC will offer DarioHealth's platform on both a stand-alone basis as well as incorporated into HMC's comprehensive care management solutions.

ShowHide Related Items >><<
DRIO DarioHealth
$18.92 /

+1.52 (+8.74%)

DRIO DarioHealth
$18.92 /

+1.52 (+8.74%)

08/17/20 Aegis
DarioHealth initiated with a Buy at Aegis
08/13/20 Craig-Hallum
DarioHealth price target raised to $17 from $8 at Craig-Hallum
06/22/20 ThinkEquity
DarioHealth initiated with a Buy at ThinkEquity
03/18/20 Craig-Hallum
DarioHealth price target lowered to $7 from $12 at Craig-Hallum
DRIO DarioHealth
$18.92 /

+1.52 (+8.74%)

Syndicate
DarioHealth files to sell 3.825M shares of common stock for holders  16:16
09/08/20
09/08
16:16
09/08/20
16:16
DRIO

DarioHealth

$15.98 /

+0.08 (+0.50%)

 
ShowHide Related Items >><<
DRIO DarioHealth
$15.98 /

+0.08 (+0.50%)

DRIO DarioHealth
$15.98 /

+0.08 (+0.50%)

08/17/20 Aegis
DarioHealth initiated with a Buy at Aegis
08/13/20 Craig-Hallum
DarioHealth price target raised to $17 from $8 at Craig-Hallum
06/22/20 ThinkEquity
DarioHealth initiated with a Buy at ThinkEquity
03/18/20 Craig-Hallum
DarioHealth price target lowered to $7 from $12 at Craig-Hallum
DRIO DarioHealth
$15.98 /

+0.08 (+0.50%)

Conference/Events
DarioHealth participates in a conference call with Stephens » 10:25
08/18/20
08/18
10:25
08/18/20
10:25
DRIO

DarioHealth

$18.00 /

-0.58 (-3.12%)

Healthcare IT Analyst…

Healthcare IT Analyst Schoenhaus holds a conference call with CEO Raphael and President & General Manager Anderson on August 18 at 11 am hosted by Stephens.

ShowHide Related Items >><<
DRIO DarioHealth
$18.00 /

-0.58 (-3.12%)

DRIO DarioHealth
$18.00 /

-0.58 (-3.12%)

08/17/20 Aegis
DarioHealth initiated with a Buy at Aegis
08/13/20 Craig-Hallum
DarioHealth price target raised to $17 from $8 at Craig-Hallum
06/22/20 ThinkEquity
DarioHealth initiated with a Buy at ThinkEquity
03/18/20 Craig-Hallum
DarioHealth price target lowered to $7 from $12 at Craig-Hallum
DRIO DarioHealth
$18.00 /

-0.58 (-3.12%)

Conference/Events
DarioHealth participates in a conference call with Stephens » 04:55
08/18/20
08/18
04:55
08/18/20
04:55
DRIO

DarioHealth

$18.58 /

+2.04 (+12.33%)

Healthcare IT Analyst…

Healthcare IT Analyst Schoenhaus holds a conference call with CEO Raphael and President & General Manager Anderson on August 18 at 11 am hosted by Stephens.

ShowHide Related Items >><<
DRIO DarioHealth
$18.58 /

+2.04 (+12.33%)

DRIO DarioHealth
$18.58 /

+2.04 (+12.33%)

08/17/20 Aegis
DarioHealth initiated with a Buy at Aegis
08/13/20 Craig-Hallum
DarioHealth price target raised to $17 from $8 at Craig-Hallum
06/22/20 ThinkEquity
DarioHealth initiated with a Buy at ThinkEquity
03/18/20 Craig-Hallum
DarioHealth price target lowered to $7 from $12 at Craig-Hallum
DRIO DarioHealth
$18.58 /

+2.04 (+12.33%)

Initiation
DarioHealth initiated with a Buy at Aegis » 10:06
08/17/20
08/17
10:06
08/17/20
10:06
DRIO

DarioHealth

$16.10 /

-0.44 (-2.66%)

Aegis analyst Nathan…

Aegis analyst Nathan Weinstein initiated coverage of DarioHealth with a Buy rating and $25 price target.

ShowHide Related Items >><<
DRIO DarioHealth
$16.10 /

-0.44 (-2.66%)

DRIO DarioHealth
$16.10 /

-0.44 (-2.66%)

08/13/20 Craig-Hallum
DarioHealth price target raised to $17 from $8 at Craig-Hallum
06/22/20 ThinkEquity
DarioHealth initiated with a Buy at ThinkEquity
03/18/20 Craig-Hallum
DarioHealth price target lowered to $7 from $12 at Craig-Hallum
12/04/19 Craig-Hallum
DarioHealth price target lowered to $12 from $20 at Craig-Hallum
DRIO DarioHealth
$16.10 /

-0.44 (-2.66%)

Conference/Events
DarioHealth participates in a conference call with Stephens » 14:43
08/13/20
08/13
14:43
08/13/20
14:43
DRIO

DarioHealth

$16.00 /

+1.47 (+10.12%)

Healthcare IT Analyst…

Healthcare IT Analyst Schoenhaus holds a conference call with CEO Raphael and President & General Manager Anderson on August 18 at 11 am hosted by Stephens.

ShowHide Related Items >><<
DRIO DarioHealth
$16.00 /

+1.47 (+10.12%)

DRIO DarioHealth
$16.00 /

+1.47 (+10.12%)

08/13/20 Craig-Hallum
DarioHealth price target raised to $17 from $8 at Craig-Hallum
06/22/20 ThinkEquity
DarioHealth initiated with a Buy at ThinkEquity
03/18/20 Craig-Hallum
DarioHealth price target lowered to $7 from $12 at Craig-Hallum
12/04/19 Craig-Hallum
DarioHealth price target lowered to $12 from $20 at Craig-Hallum
DRIO DarioHealth
$16.00 /

+1.47 (+10.12%)

Recommendations
DarioHealth price target raised to $17 from $8 at Craig-Hallum » 08:35
08/13/20
08/13
08:35
08/13/20
08:35
DRIO

DarioHealth

$14.53 /

+0.85 (+6.21%)

Craig-Hallum analyst…

Craig-Hallum analyst Alexander Nowak raised the firm's price target on DarioHealth to $17 from $8 and keeps a Buy rating on the shares. The analyst notes DarioHealth traded up sharply after reporting Q2 revenue ahead of the Street and indicating 2021 will be above consensus. The company was largely insulated from COVID in Q2 and may have even seen a benefit as the world shifts to remote monitoring solutions, he adds.

ShowHide Related Items >><<
DRIO DarioHealth
$14.53 /

+0.85 (+6.21%)

DRIO DarioHealth
$14.53 /

+0.85 (+6.21%)

06/22/20 ThinkEquity
DarioHealth initiated with a Buy at ThinkEquity
03/18/20 Craig-Hallum
DarioHealth price target lowered to $7 from $12 at Craig-Hallum
12/04/19 Craig-Hallum
DarioHealth price target lowered to $12 from $20 at Craig-Hallum
DRIO DarioHealth
$14.53 /

+0.85 (+6.21%)

Earnings
DarioHealth reports Q2 EPS (68c), consensus ($1.40) » 07:05
08/12/20
08/12
07:05
08/12/20
07:05
DRIO

DarioHealth

$13.68 /

-1.5 (-9.88%)

Reports Q2 revenue…

Reports Q2 revenue $1.79M, consensus $1.55M. "The COVID-19 pandemic has accelerated our ongoing transformation to a business-to-business-to-consumer digital therapeutics leader," said CEO Erez Raphael. "We advanced late-stage discussions with health plans and self-insured employers, who we believe recognize how our industry-leading user engagement and satisfaction metrics lead to improved health for their member and employee populations. Our pipeline continues to grow and mature, and although the normal sales cycle can be lengthy, we believe that we are poised to announce new and potentially transformational agreements in the next few weeks. At the same time, our Remote Patient Monitoring product offering, which was just recently introduced, is seeing significant traction as evidenced by recently announced agreements in the U.S. and U.K. with more potential agreements in the pipeline."

ShowHide Related Items >><<
DRIO DarioHealth
$13.68 /

-1.5 (-9.88%)

DRIO DarioHealth
$13.68 /

-1.5 (-9.88%)

06/22/20 ThinkEquity
DarioHealth initiated with a Buy at ThinkEquity
03/18/20 Craig-Hallum
DarioHealth price target lowered to $7 from $12 at Craig-Hallum
12/04/19 Craig-Hallum
DarioHealth price target lowered to $12 from $20 at Craig-Hallum
DRIO DarioHealth
$13.68 /

-1.5 (-9.88%)

Earnings
DarioHealth reports Q2 EPS (68c), consensus ($1.40) » 07:03
08/12/20
08/12
07:03
08/12/20
07:03
DRIO

DarioHealth

$13.68 /

-1.5 (-9.88%)

Reports Q2 revenue…

Reports Q2 revenue $1.79M, consensus $1.55M. "The COVID-19 pandemic has accelerated our ongoing transformation to a business-to-business-to-consumer digital therapeutics leader," said CEO Erez Raphael. "We advanced late-stage discussions with health plans and self-insured employers, who we believe recognize how our industry-leading user engagement and satisfaction metrics lead to improved health for their member and employee populations. Our pipeline continues to grow and mature, and although the normal sales cycle can be lengthy, we believe that we are poised to announce new and potentially transformational agreements in the next few weeks. At the same time, our Remote Patient Monitoring product offering, which was just recently introduced, is seeing significant traction as evidenced by recently announced agreements in the U.S. and U.K. with more potential agreements in the pipeline."

ShowHide Related Items >><<
DRIO DarioHealth
$13.68 /

-1.5 (-9.88%)

DRIO DarioHealth
$13.68 /

-1.5 (-9.88%)

06/22/20 ThinkEquity
DarioHealth initiated with a Buy at ThinkEquity
03/18/20 Craig-Hallum
DarioHealth price target lowered to $7 from $12 at Craig-Hallum
12/04/19 Craig-Hallum
DarioHealth price target lowered to $12 from $20 at Craig-Hallum
DRIO DarioHealth
$13.68 /

-1.5 (-9.88%)

Over a quarter ago
Hot Stocks
DarioHealth announces strategic partnership with Williams Medical » 08:32
07/20/20
07/20
08:32
07/20/20
08:32
DRIO

DarioHealth

$6.20 /

-0.01 (-0.16%)

DarioHealth announced…

DarioHealth announced that the company has entered into a new strategic partnership with Williams Medical to make the DarioHealth Remote Patient Monitoring, or RPM, digital therapeutics platform available to Healthcare Professionals, or HCPs, across the U.K.and Ireland. Dario's turn-key RPM solution integrates the company's existing open platform, application technology, and the DarioEngage coaching platform, to allow Healthcare Professionals to monitor their patients remotely. Dario's digital solution is intended to provide relief for primary and secondary care providers challenged by the COVID-19 pandemic and facing potential serious winter pressures in the healthcare system.

ShowHide Related Items >><<
DRIO DarioHealth
$6.20 /

-0.01 (-0.16%)

DRIO DarioHealth
$6.20 /

-0.01 (-0.16%)

06/22/20 ThinkEquity
DarioHealth initiated with a Buy at ThinkEquity
03/18/20 Craig-Hallum
DarioHealth price target lowered to $7 from $12 at Craig-Hallum
12/04/19 Craig-Hallum
DarioHealth price target lowered to $12 from $20 at Craig-Hallum
DRIO DarioHealth
$6.20 /

-0.01 (-0.16%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.